Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Sales		$ 3,017		$ 77,044
Cost of Sales		(2,971)		(75,327)
Gross Profit		46		1,717
Operating expenses:
Research and development	291,104	393,747	1,332,664	980,862
General and administrative	1,250,149	1,230,160	4,317,358	1,509,095
Total operating expenses	1,541,253	1,623,907	5,650,022	2,489,957
Loss from operations	(1,541,253)	(1,623,907)	(5,650,022)	(2,488,240)
Other income (expense)
Interest expense	(1,925,678)	(1,082,949)	(3,407,499)	(4,152,437)
Change in fair value of warrant liability	1,003,000		2,600,000
Change in fair value of foreign exchange contract derivative liability	302,453	990,532	489,435	(2,820,211)
Net loss	(2,161,478)	(1,716,278)	(5,968,086)	(9,460,888)
Other comprehensive loss:
Foreign currency translation adjustment	204,828	(556,080)	(44,327)	(864,328)
Comprehensive loss	$ (1,956,650)	$ (4,831,171)	$ (6,012,413)	$ (10,325,216)